Seminários

Sofia Ravara is a Portuguese board certified respiratory physician with a master degree in Tobacco Control (TC) (Cantabria University, Spain, 2006) and a PhD degree in Medicine (University of Beira Interior-UBI, Portugal, 2016). From 1990 to 2008, Dr. Ravara worked at the Medicine and Respiratory Departments of several major Lisbon Hospitals. Her main clinical activity has been Asthma, COPD, non-invasive ventilation support and care in respiratory intermediate care units, respiratory infection and tuberculosis and smoking cessation. Since 2008 up to the present Dr. Ravara is a lecturer in Preventive Medicine and Epidemiology, at the Faculty of Health Sciences, UBI, Portugal. Dr. Ravara also holds the clinical position of Head of the Tobacco Treatment Unit of the University Hospital in Covilhã. During the last years she has worked as a tobacco treatment expert in hospital-based smoking quit clinics and workplace smoking prevention programs, in the development of the smoke-free hospitals network, as well as in health professionals training programs. Dr Ravara has also been very active in TC activities in Portugal and Europe, as an active member of the Portuguese Respiratory Society (SPP), Tobacco Control Committee and Scientific group of Smoking Cessation of the European Respiratory Society (ERS) and International Network of Women Against Tobacco INWAT-Europe. She has been involved in European TC advocacy, smoking cessation network groups and Tobacco Control and epidemiologic research

Curriculum Vitae

Afiliada ao SINSEF ( Sindicato dos Funcionários do SEF)

Universidade Fernando Pessoa

Graduated in Architecture and Urbanism in the 80s, subsequently graduated in addiction counseling and in Psychopedagogy in the 90s. In 2002 he completed the Master of Public Health at the National Public Health and School of the New University of Lisbon.

In 2016, he is completing a PhD in Life Sciences, specializing in Public Health, Faculty of Medical Sciences, New University of Lisbon and waiting for the doctoral examination. In PhD final thesis he addresses the theme of alcohol policies in Portugal. Collaborates as a university lecturer and is a researcher in Public Health since 2002.

Since 1992 works in prevention and treatment of substance use (alcohol, tobacco and other drugs) and since 1999 acts on the field of tobacco control and alcohol and drug policies, representing NGOs before various government agencies.

Since 2002 he wrote several scientific papers and organized and was the author of nine technical books on the subject of alcohol, tobacco and other drugs’ use and abuse, and in the field of counseling. These books address issues such as public policy, epidemiology, health promotion and protection, law, health problems associated with the use, organization of health care and more effective therapeutic approaches. 

Isabel Saraiva was born in Portugal in 1949. She holds a degree in Economics from ISCEF (Advanced Institute for Economics and Finance, Technical University of Lisbon), a post-graduation in Association Executive Management from the University of Delaware (Wilmington, DE, USA), a post-graduation in Business Administration from AESE Business School (Lisbon), and a post-graduation in Social and Solidary Economics from ISCTE (University Institute of Lisbon).

Till 2007 she was Executive Director of Apifarma-The Portuguese Pharmaceutical Trade Association, and in that capacity she was the representative to the European and International institutions related with Pharmaceutical Industry, Labour and Industry Relations, and to the correspondent Portuguese institutions as well. Previously she was Director-General of CIP-Confederation of Portuguese Industry.

Presently she works in a pro bono basis with several institutions. She is member of RESPIRA-Portuguese Association of People with COPD and other Chronic Respiratory Diseases, where she was Board Member and Treasurer and worked in patient advocacy, media relations, and institutional affairs [www.respira.pt]. Since January 2013 she is an EMA expert. (EMA-European Medicines Agency is a decentralized agency of the European Union located in London) [www.ema.europa.eu]. In June 2014 she was elected as member of the Board of EFA (European Federation of Allergy and Airways Diseases Patients’ Associations, Brussels) [www.efanet.org]. She is member of the Competitiveness Forum Audit Committee (Lisbon) [http://forumcompetitividade.org].

She is a frequent speaker in conferences, in Portugal and abroad, related with Healthcare issues, mainly Pharmaceutical Industry, the role of Patient Associations, and Chronic Respiratory Diseases.

Paraskevi Katsaounou is an Assistant Professor of Pulmonary Medicine
of National and Kapodistrian University of Athens.

She is an experienced clinician at the 1rst ICU Clinic of Evaggelismos Hospital. She is also running the Asthma and Smoking Cessation Outpatient Clinic of Evaggelsimos Athens Hospital. She is the Chair of Smoking Cessation and Public Health Group of Hellenic Thoracic Society and Chair of  Group 6.3 Tobacco, Smoking Cessation and Health Education ERS.

She is also a member of Tobacco Control Committee of European Respiratory Society. She has been active in Tobacco Control and Smoking Cessation the last twelve years. She is a qualified trainner in Smoking Cessation of Hellenic Thoracic Society, ERS and WHO. She is on the Editorial board member of Tobacco Cessation and Prevention Journal.

Mervi Hara is a Master of Political Sciences and the executive director of Finland´s ASH. She has worked in tobacco control over 30 years.  She promotes and develops Finnish tobacco control legislation and the idea of endgame, activates co-operation on tobacco-related issues, consults on tobacco policy and health and carries out number of national projects on tobacco policy. She was a key person in preparing the proposals for the Tobacco-free Finland launched in the end of 2013. 

She was the founding member Finland´s INWAT (International Network of Women Against Tobacco) and is currently member of the advisory board of INWAT Europe. Among all, Mrs. Hara acts as a tobacco control expert in Kyrgyzstan. She received a Golden Helsinki Medal for her work to promote and support Tobacco-free Helsinki.

Margaretha Haglund, is a recognized expert in tobacco control both in Sweden and globally. She has a broad expertise in tobacco control in particular women and tobacco. In between 1979-1992 she was the head of tobacco control at the National Board of Health and Welfare. 1992-2011 she had the same position in the Institute of Public Health. Since 2011 she serves as an expert at ThinkTank Tobaksfakta (an independant NGO) in Sweden. Margaretha is also the past president of the International Network of Women Against Tobacco (INWAT). In 1994 she received the May 31 st WHO medal and in 2006 the prestigious Luther Terry Award.

Full Professor, Coimbra Medical School

Head, Pneumology Department, Coimbra University Hospital 

Director do jornal especializado “SaúdeOline”, e responsável pela secção “Saúde” do Jornal Económico, foi ainda editor-chefe da revista Qualidade em Saúde e chefe de redacção de diversas publicações, entre as quais “A Revista”, “Manchete”, “Interfarma” e “Jornal Hospitalar”.

Membro do Conselho Nacional da Droga e Toxicodependência, integrou ainda o Conselho Consultivo da Comissão Nacional da Luta Contra a SIDA.

Na área da qualidade, foi membro da Comissão Consultiva na SGS – ICS Internacional, empresa de certificação e auditoria da qualidade.

Ao longo do seu percurso profissional, participou, como orador, em mais de duas centenas de conferências, nacionais e internacionais, participando ainda, como palestrante ou formador, com alguma assiduidade, em cursos de pós-graduação e mestrados na área dos sistemas de comunicação de risco em saúde, Na Universidade de Coimbra e na Escola Nacional de Saúde Público, UNL

Consultora de Infecciologia e Diretora Médica do H. Egas Moniz-CHLO. Assistente Convidada de Doenças Infeciosas da FCML. Diretora do Programa Nacional para a Infeção VIH, Sida e Tuberculose, e do Programa Nacional para as Hepatites Virais, da DGS. Membro do Conselho Fiscal da APECS e da Direção do Colégio de Doenças Infeciosas. Pós-Graduação em Parasitologia, Microbiologia Médica e Clínica de Doenças Tropicais, do IHMT; Pós-Graduação em Gestão de Unidades de Saúde na FCEE - U. Católica Portuguesa; Programa de Alta Direção de Instituições de Saúde da AESE. Membro da missão de ajuda humanitária à ilha de Sumatra em Janeiro de 2006, e da missão da União Europeia de avaliação da epidemia de febre amarela em Angola em Maio de 2016.

Henrique Barros nasceu em 1957 no Porto. Licenciou-se em Medicina em 1981 e é docente da Faculdade de Medicina do Porto (FMUP) desde 1979. Em 1988-89 foi investigador no departamento de Medicina Interna do Hospital Universitário de Lund. Em 1991 adquiriu o título de assistente hospitalar de Gastrenterologia e doutorou-se com uma investigação epidemiológica sobre hepatites víricas. É Professor Catedrático de Epidemiologia desde 1999. Trabalhou na criação dos mestrados de Saúde Pública (que coordena), Epidemiologia, Educação para a Saúde e Sociologia e Saúde, bem como dos programas de doutoramento em Saúde Publica da Universidade do Porto e em Saúde Pública Global – um programa académico baseado no ensino e investigação de quatro escolas portuguesas, financiado pela FCT, que dirige. Tem desenvolvido trabalho de investigação em projetos nacionais e internacionais, em áreas como a epidemiologia clínica e perinatal, as doenças cardiovasculares, infeciosas e o cancro, que resultou em mais de 200 publicações científicas internacionais. É diretor da revista Arquivos de Medicina, membro do conselho editorial do European Journal of Epidemiology. Foi membro do Conselho Científico para as Ciências da Saúde da Fundação para a Ciência e a Tecnologia (2004-12). Foi Coordenador Nacional para a Infeção VIH/ Sida (2005-11) e Presidente da Associação Portuguesa de Epidemiologia (2013-15). Atualmente é o Presidente do Instituto de Saúde Pública da Universidade do Porto, membro da comissão executiva da Comissão de Ética para a Investigação Clínica e do comité científico da Science Europe (MED) desde 2013. Integra a direção da IEA – International Epidemiological Association como presidente-eleito no triénio 2014-2017.